Results 361 to 370 of about 832,143 (393)

Migraine symptomatology and major depressive disorder

Cephalalgia, 2010
Introduction and objective: Migraine and major depressive disorder (MDD) frequently co-occur, but it is unclear whether depression is associated with a specific subtype of migraine. The objective of this study was to investigate whether migraine is qualitatively different in MDD patients ( N = 1816) and non-depressed controls ( N = 3428).
Dale R. Nyholt, Dorret I. Boomsma, Johannes H. Smit, Lannie Ligthart, Gonneke Willemsen, Marijn A. Distel, Eco J. C. de Geus, Brenda W.J.H. Penninx, Brenda W.J.H. Penninx, Brenda W.J.H. Penninx   +9 more
openaire   +8 more sources

Major Depressive Disorder

Abstract This chapter looks at the section on Major Depressive Disorder in the Anxiety and Related Disorders Interview Schedule for DSM-5, Child Version: Parent Interview Schedule (PIS). If the parent responds “Yes” to Question 1a and “No” to Question 1b (parent reports past depression but denies current episode), the interviewer should ...
Anne Marie Albano, Wendy K. Silverman
openaire   +1 more source

MicroRNAs in Major Depressive Disorder

2019
Major depressive disorder (MDD) is a severe and chronic psychiatric disorder with a high prevalence in the population. Although our understanding of its pathophysiological mechanisms has significantly increased over the years, available treatments still present several limitations and are not effective to all MDD patients.
Deborah Benevenuto, Wei Zhang, João Quevedo, Gabriel Rodrigo Fries   +3 more
openaire   +3 more sources

Epigenetics of Major Depressive Disorder

2020
Epigenetic modifications can alter gene expression through mechanisms that are heritable, but do not involve direct changes in the nucleotide sequence of the genome. Recent findings have suggested that epigenetic modifications are associated with several psychiatric disorders.
Wang K. Z., Dada O. O., Bani-Fatemi A., Tasmim S., Monda M., Graff A., De Luca V.   +6 more
openaire   +1 more source

Ketamine for Major Depressive Disorder

2023
Major Depressive Disorder (MDD) is a leading cause of disability worldwide. Conventional antidepressant treatment is characterised by a significant time to onset of therapeutic action (approximately 2 weeks) and fails to achieve a stable remission of symptoms in one-third of subjects with MDD.
openaire   +2 more sources

Hormones and Major Depressive Disorder

2019
Hormonal influences figure prominently in the development of major depressive disorder (MD). The chapter addresses the hypothalamic-pituitary-adrenal (HPA) axis and gonadal (i.e., estrogen and testosterone) hormones that are most relevant to MD. There is substantial evidence of HPA dysfunction in persons with MD, including adrenal hypersensitivity ...
Mark A. Ellenbogen, Lisa Serravalle, Virginia Tsekova   +2 more
openaire   +2 more sources

Networks of major depressive disorder: A systematic review.

Clinical Psychology Review, 2021
M. Malgaroli, Adam Calderon, G. Bonanno
semanticscholar   +1 more source

Clinical management of metastatic colorectal cancer in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2022
, Davide Ciardiello, Giulia Martini
exaly  

Major depressive disorders

Hot Topics in Neurology and Psychiatry, 2011
Alessandro Colasanti, Vaishnav Krishnan, Allan H. Young   +2 more
openaire   +1 more source

American Cancer Society's report on the status of cancer disparities in the United States, 2021

Ca-A Cancer Journal for Clinicians, 2022
Farhad Islami, Carmen E Guerra, K Robin Yabroff   +2 more
exaly